Granted Patent
Utility
US 6,677,366
· Confirmation No. 9799
METHODS, COMPOSITIONS AND ARTICLES FOR REDUCING OR PREVENTING THE EFFECTS OF INFLAMMATION
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2002-01-09 | TRNA |
Transmittal of New Application | 2 | View | |
| 2002-01-09 | DRW |
Drawings-only black and white line drawings | 8 | View | |
| 2002-01-09 | OATH |
Oath or Declaration filed | 6 | View | |
| 2002-01-09 | LET. |
Miscellaneous Incoming Letter | 1 | View | |
| 2001-08-13 | TRNA |
Transmittal of New Application | 2 | View | |
| 2001-08-13 | ADS |
Application Data Sheet | 3 | View | |
| 2001-08-13 | A.PE |
Preliminary Amendment | 4 | View | |
| 2001-08-13 | SPEC |
Specification | 46 | View | |
| 2001-08-13 | CLM |
Claims | 4 | View | |
| 2001-08-13 | ABST |
Abstract | 1 | View | |
| 2001-08-13 | DRW |
Drawings-only black and white line drawings | 7 | View | |
| 2001-08-13 | LET. |
Miscellaneous Incoming Letter | 1 | View |
Inventors
Anna M. Richter
Vancouver, CANADA
Julia G. Levy
Vancouver, CANADA
Claude A. A. Hariton
Sillery, CANADA
Gustave Huber
Rafz, SWITZERLAND
William C. Stewart
James Island, SC
Mario G. Fsadni
Bulach, SWITZERLAND
Modestus O.K Obochi
Vancouver, CANADA
Attorneys & Agents of Record
Classification
USPC
514/410
Prosecution
- Examiner
- FAY, ZOHREH ALEMZADEH
- Art Unit
- 1614
- Customer No.
- 25225
- Docket No.
- 273012010202
- Confirmation No.
- 9799
Publication
- Pub. No.
- US20020103180A1
- Pub. Date
- 2002-08-01
Patent Term Adjustment
-108days
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
SECURITY INTEREST
Recorded 2017-07-19
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSH & LOMB PHARMA HOLDINGS CORP.,
DENDREON PHARMACEUTICALS, INC.,
DOW PHARMACEUTICAL SCIENCES, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
OBAGI MEDICAL PRODUCTS, INC.,
OMP, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED,
VALEANT HOLDINGS IRELAND (AS SUCCESSOR TO VALEANT INTERNATIONAL BERMUDA),
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
SECURITY INTEREST
Recorded 2016-07-18
ADDRESS CHANGE
Recorded 2014-05-15
PATENT ASSIGNMENT AGREEMENT
Recorded 2013-12-09
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,677,366
- App. No.
- 09/929,558
- Filed
- 2001-08-13
- Granted
- 2004-01-13
- Pub. No.
- US20020103180A1
- Examiner
- FAY, ZOHREH ALEMZADEH
- Art Unit
- 1614
- PTA
- -108 days
External Links